GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » LT-Debt-to-Total-Asset

Oventus Medical (ASX:OVN) LT-Debt-to-Total-Asset : 0.02 (As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Oventus Medical's long-term debt to total assests ratio for the quarter that ended in Dec. 2021 was 0.02.

Oventus Medical's long-term debt to total assets ratio declined from Dec. 2020 (0.04) to Dec. 2021 (0.02). It may suggest that Oventus Medical is progressively becoming less dependent on debt to grow their business.


Oventus Medical LT-Debt-to-Total-Asset Historical Data

The historical data trend for Oventus Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical LT-Debt-to-Total-Asset Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
LT-Debt-to-Total-Asset
- - - - 0.02

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - 0.04 0.02 0.02

Oventus Medical LT-Debt-to-Total-Asset Calculation

Oventus Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2021 is calculated as

LT Debt to Total Assets (A: Jun. 2021 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2021 )/Total Assets (A: Jun. 2021 )
=0.32/15.079
=0.02

Oventus Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (Q: Dec. 2021 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2021 )/Total Assets (Q: Dec. 2021 )
=0.24/9.861
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oventus Medical  (ASX:OVN) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Oventus Medical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Oventus Medical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines